Our Mission

Dermadis is a Biotech company which discovers and develops drugs using natural human proteins and peptides as a starting point, to create more selective or reactive regulators of biological pathways involved in dermatology disorders such as Netherton Syndrome, psoriasis and acute atopic dermatitis. Dermadis wants to become a lead player in the development of treatments for important dermatology disorders based on kallikrein targetting

 
News

Dermadis announces executive promotion
Read more

Dermadis moved in new facilities
Read more